OGN:NYSE
Organon & Co
13,72 US$
arrow_downward
-0,07%(-0,010) 1K
2-okt, 11:24:30 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoOGN tikeri uchun statistika yaratilmoqda...
Ochish
13,71 US$
Yuqori
13,73 US$
Past
13,71 US$
Bozor kapitali
3,60 mlrd
Oʻrtacha hajm
2,83 mln
Hajmi
301,14 ming
Dividend
0,58%
Choraklik dividendlar
0,02 US$
Eks-dividend sanasi
14-avg, 2026
P/E koeffitsiyenti
17,57
52 haftalik eng yuqori
13,78 US$
52 haftalik eng past
5,69 US$
Aksiya boʻyicha daromad
0,78 US$
Beta
1,55
Muomaladagi aksiyalar
262,61 mln
Xodimlar soni
10 ming
Ochish
13,71 US$
Yuqori
13,73 US$
Past
13,71 US$
Bozor kapitali
3,60 mlrd
Oʻrtacha hajm
2,83 mln
Hajmi
301,14 ming
Dividend
0,58%
Choraklik dividendlar
0,02 US$
Eks-dividend sanasi
14-avg, 2026
P/E koeffitsiyenti
17,57
52 haftalik eng yuqori
13,78 US$
52 haftalik eng past
5,69 US$
Aksiya boʻyicha daromad
0,78 US$
Beta
1,55
Muomaladagi aksiyalar
262,61 mln
Xodimlar soni
10 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Zacks
·
2 soat oldin
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Yahoo Finance
·
3 soat oldin
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
AD HOC NEWS
·
18 soat oldin
Organon presents VTAMA analysis: Organon stock gains 1.16 percent
Yahoo Finance
·
1 kun oldin
Organon & Co. (OGN) Stock Forecasts
Profil
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Organon & Co haqida
CEO-
Xodimlar soni10 ming
Asos solingan1923
Bosh ofislarJersey City, N'yu-Jersi, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytorganon.com